Security key
N5749R100
Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS)
CUSIP: N5749R100
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Shares, (euro)0.09 nominal value per share
- Shares outstanding
- 75,893,250
- Total 13F shares
- 22,046,847
- Share change
- +3,148,632
- Total reported value
- $386,593,075
- Price per share
- $17.53
- Number of holders
- 43
- Value change
- +$58,495,806
- Number of buys
- 21
- Number of sells
- 16
Report period
Q4 2020
Institutions
43
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP N5749R100
Recent filing periods:
Top shareholders of MRUS - Merus N.V. - Common Shares, (euro)0.09 nominal value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) as of Q4 2020
As of 31 Dec 2020,
Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,046,847 shares.
The largest 10 holders included
BVF INC/IL, FEDERATED HERMES, INC., BAKER BROS. ADVISORS LP, Medicxi Ventures Management (Jersey) Ltd, BOXER CAPITAL, LLC, Sofinnova Investments, Inc., WELLINGTON MANAGEMENT GROUP LLP, DRIEHAUS CAPITAL MANAGEMENT LLC, MPM ONCOLOGY IMPACT MANAGEMENT, L.P., and MPM Oncology Impact Management LP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
41
Q4 2020 holders
43
Holder diff
2
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.